Thyroid nodules
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cystic or predominantly cystic thyroid nodule (> 80%); 2. Nodal diameter > 2 cm; 3. The patient has not been treated by radioactive iodine, TSH suppression therapy, etc; 4. Ultrasound revealed no characteristics of malignant nodules; 5. The patient's own conditionTheir own conditions can't tolerance to traditional surgery, or the patient reject the traditional surgery; 6. Including one of the following situations: nodule visibly increased, local symptoms, such as foreign body sensation, neck discomfort; nodules affect appearance so the patient required treatment; patients thought concerns is overweight and their normal life is affected; 7. Voluntary participation in clinical trials and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Ultrasound prompted the possibility of malignant nodules; 2. Lesions of contralateral vocal cord dysfunction; 3. Severe coagulation disorders; 4. Serious heart, cerebrovascular diseases, respiratory diseases, liver and kidney dysfunction complications, such as intolerance to treatment; 5. Refused to participate in this experiment or refuse to sign the informed consent; 6. Suspend the standard of clinical trials; 7. Do not accord with standard of cases into the group; 8. Asked to quit the study; 9. Intraoperative complications appeared in the process of treatment led to the suspension of therapy; 10. Researchers from the medical point of view that the subjects need to be to suspend the test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume reduction ratio; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications;Blood score;The recurrence rate; | — |
Countries
China
Contacts
PLA 323th Hospital